These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21524870)

  • 21. The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).
    Vaidya T; Agrawal A; Mahajan S; Thakur MH; Mahajan A
    Mol Diagn Ther; 2019 Feb; 23(1):1-26. PubMed ID: 30411216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemistry of tumour targeted T1 based MRI contrast agents.
    Kamaly N; Miller AD; Bell JD
    Curr Top Med Chem; 2010; 10(12):1158-83. PubMed ID: 20388110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer.
    Yankeelov TE; Arlinghaus LR; Li X; Gore JC
    Semin Oncol; 2011 Feb; 38(1):16-25. PubMed ID: 21362513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.
    Xue S; Qiao J; Pu F; Cameron M; Yang JJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(2):163-79. PubMed ID: 23335551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards the Molecular Imaging of Prostate Cancer Biomarkers Using Protein-based MRI Contrast Agents.
    Pu F; Xue S; Qiao J; Patel A; Yang JJ
    Curr Protein Pept Sci; 2016; 17(6):519-33. PubMed ID: 26721404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor models and specific contrast agents for small animal imaging in oncology.
    Ni Y; Wang H; Chen F; Li J; DeKeyzer F; Feng Y; Yu J; Bosmans H; Marchal G
    Methods; 2009 Jun; 48(2):125-38. PubMed ID: 19328231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translational molecular imaging for cancer.
    Pomper MG
    Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S16-26. PubMed ID: 16361132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiparametric and molecular imaging of breast tumors with MRI and PET/MRI].
    Pinker K; Marino MA; Dr Meyer-Baese A; Helbich TH
    Radiologe; 2016 Jul; 56(7):612-21. PubMed ID: 27364727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific detection of CD133-positive tumor cells with iron oxide nanoparticles labeling using noninvasive molecular magnetic resonance imaging.
    Chen YW; Liou GG; Pan HB; Tseng HH; Hung YT; Chou CP
    Int J Nanomedicine; 2015; 10():6997-7018. PubMed ID: 26635474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical applications of imaging biomarkers. Part 3. The neuro-oncologist's perspective.
    Shenoy A
    Br J Radiol; 2011 Dec; 84 Spec No 2(Spec Iss 2):S209-12. PubMed ID: 22433830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PET in oncology: will it replace the other modalities?
    Hoh CK; Schiepers C; Seltzer MA; Gambhir SS; Silverman DH; Czernin J; Maddahi J; Phelps ME
    Semin Nucl Med; 1997 Apr; 27(2):94-106. PubMed ID: 9144854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.
    Höink AJ; Heindel W; Buerke B
    Rofo; 2014 Oct; 186(10):927-36. PubMed ID: 25122173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An introduction to functional and molecular imaging with MRI.
    Gallagher FA
    Clin Radiol; 2010 Jul; 65(7):557-66. PubMed ID: 20541655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuroimaging in brain tumors].
    Arbizu J; Domínguez PD; Diez-Valle R; Vigil C; García-Eulate R; Zubieta JL; Richter JA
    Rev Esp Med Nucl; 2011; 30(1):47-65. PubMed ID: 21211868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution.
    Kim JY; Gatenby RA
    Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing MR probes for molecular imaging.
    McMahon MT; Chan KW
    Adv Cancer Res; 2014; 124():297-327. PubMed ID: 25287693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging biomarkers in primary brain tumours.
    Lopci E; Franzese C; Grimaldi M; Zucali PA; Navarria P; Simonelli M; Bello L; Scorsetti M; Chiti A
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(4):597-612. PubMed ID: 25520293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction and prognosis of biologically aggressive breast cancers by the combination of DWI/DCE-MRI and immunohistochemical tumor markers.
    Allarakha A; Gao Y; Jiang H; Wang PJ
    Discov Med; 2019 Jan; 27(146):7-15. PubMed ID: 30695671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
    Padhani AR
    J Magn Reson Imaging; 2002 Oct; 16(4):407-22. PubMed ID: 12353256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.